Amanote Research
Register
Sign In
Toll-Like Receptor 9 (TLR9) or TLR3 Adjuvants to Promote Cancer Vaccine–induced Effector T Cell Expansion
Science-Business eXchange
doi 10.1038/scibx.2013.1207
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Augmented NRF2 Activation Protects Adult Sickle Mice From Lethal Acute Chest Syndrome
British Journal of Haematology
Hematology
Blockade of TLR3 Protects Mice From Lethal Radiation-Induced Gastrointestinal Syndrome
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Transgenic Mice Neutrophils in Increased Susceptibility to Acute Lung Injury- Implications for Sickle Acute Chest Syndrome † 767
Pediatric Research
Child Health
Pediatrics
Perinatology
COVID-19 Pneumonia as a Cause of Acute Chest Syndrome in an Adult Sickle Cell Patient
American Journal of Hematology
Hematology
Nrf2 Protects Stellate Cells From Smad-Dependent Cell Activation
PLoS ONE
Multidisciplinary
Schisandrol B Protects Against Acetaminophen-Induced Acute Hepatotoxicity in Mice via Activation of the NRF2/ARE Signaling Pathway
Acta Pharmacologica Sinica
Medicine
Pharmacology
Aeroallergen Sensitization Predicts Acute Chest Syndrome in Children With Sickle Cell Anaemia
British Journal of Haematology
Hematology
The Acute Chest Syndrome in Cameroonian Children Living With Sickle Cell Disease
BMC Pediatrics
Child Health
Pediatrics
Perinatology
Amelioration of Inflammation and Tissue Damage in Sickle Cell Model Mice by Nrf2 Activation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Clinical Risk Score for Pulmonary Artery Thrombosis During Acute Chest Syndrome in Adult Patients With Sickle Cell Disease
British Journal of Haematology
Hematology
